Clinical Trials Browser

Approved for marketing × Wounds and Injuries × Clear all

NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Approved for marketing

Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries